NewsRx

Search our medical news database

Pathogenesis

CD8 Cells Can Prevent CD4+ Cell-Harbored Virus Replication

Published in AIDS Weekly, March 12th, 2001

by Michael Greer, staff medical writer -- Researchers in Maryland have clarified the role played by immune cells in HIV patients responsive to treatment.

The researchers found that autologous CD8+ cells were capable, in long-term nonprogressors (LTNPs) and patients responsive to highly active antiretroviral therapy (HAART), of preventing CD4+ cell-harbored virus replication ex vivo.

"CD8+ T-cell-mediated antiviral activity against HIV has been described consistently in infected individuals," explained T.W. Chun and colleagues with the U.S. National Institute of Allergy and Infectious Diseases.

But...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook